Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | NA |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹250 | ₹100 |
Expense Ratio | 2 | 1.74 |
NAV | ₹44.58 | ₹82.07 |
Fund Started | 09 Aug 2004 | 17 Nov 2003 |
Fund Size | ₹823.92 Cr | ₹3406.09 Cr |
Exit Load | Exit load of 1% if redeemed within 6 months | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.66% | 7.05% |
3 Year | 9.85% | 12.32% |
5 Year | 8.11% | 12.32% |
1 Year
3 Year
5 Year
Equity | 22.67% | 20.96% |
Cash | -0.40% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 1.99% |
ICICI Bank Ltd. | 1.56% |
Reliance Industries Ltd. | 1.15% |
Infosys Ltd. | 0.72% |
Hitachi Energy India Ltd. | 0.68% |
Axis Bank Ltd. | 0.62% |
Hexaware Technologies Ltd. | 0.59% |
Linde India Ltd. | 0.55% |
Bharti Airtel Ltd. | 0.54% |
State Bank of India | 0.51% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Shreekiran Rao | Dhruv Muchhal |
Start Date | 01 Dec 2022 | 14 Sep 2023 |
Name
Start Date
Description | The scheme aims to generate regular returns through investment primarily in debt and money market instruments. It would also invest a portion of its assets in equity and equity related securities to generate long term appreciation. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 09 Aug 2004 | 17 Nov 2003 |
Description
Launch Date